Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Futura Medical (GYX) Stock Price & Analysis

1 Followers

GYX Stock Chart & Stats

€0.01€0.00(0.00%)
At close: 2:00 AM GMT+2
€0.01€0.0125€0.015€0.0175Mar 18Apr 14Apr 27May 14May 29
Day’s Range
EUR 0.00 - EUR 0.01
52-Week Range
EUR 0.00 - EUR 0.18
Previous Close
EUR 0.01
Volume
N/A
Average Volume (3M)
16.99K
Market Cap
EUR 3.29M
Enterprise Value
EUR 1.78M
Total Cash (Recent Filing)
EUR 1.24M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
1.39
Next Earnings
Apr 14, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-Free Balance Sheet

Zero debt reduces leverage and interest burdens, giving Futura greater financial flexibility while it commercialises MED3000. This structure lowers solvency risk and leaves the company less exposed to refinancing pressure during periods of uneven revenue or continued investment.

Strong Gross Margin

A consistently high gross margin indicates that the core product economics can be attractive before operating costs. If commercial scale improves, this margin profile could provide meaningful operating leverage, although current overheads prevent that benefit from reaching profitability.

Partner-Led Commercial Model

An out-licensing model can extend MED3000’s geographic reach without requiring Futura to build a large direct commercial organisation. Partner-led manufacturing, distribution and sales may support international expansion while keeping the company focused on regulatory and product development activities.

Bears Say

Sharp Revenue Decline And Losses

The steep revenue contraction and move into a sizable loss show that commercial performance is not yet consistent. Persistent volatility makes it harder to fund development internally, plan operating resources, or demonstrate that MED3000 can generate durable earnings across reporting periods.

Persistent Cash Burn

Ongoing negative free cash flow means the business has not yet converted its activities into self-sustaining cash generation. Continued cash burn can increase reliance on external funding and may constrain investment in regulatory approvals, commercial expansion and other growth priorities.

Shrinking Capital Base

The reduction in equity and assets indicates that losses are eroding the company’s capital base rather than building financial capacity. A smaller balance sheet can limit resilience and reduce the resources available to support MED3000’s international commercialisation over the medium term.

Futura Medical News

GYX FAQ

What was Futura Medical’s price range in the past 12 months?
Futura Medical lowest stock price was €0.00 and its highest was €0.18 in the past 12 months.
What is Futura Medical’s market cap?
Futura Medical’s market cap is €3.29M.
When is Futura Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Futura Medical’s earnings last quarter?
Futura Medical released its earnings results on Sep 01, 2026. The company reported -€0.002 earnings per share for the quarter.
Is Futura Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Futura Medical pay dividends?
Futura Medical does not currently pay dividends.
What is Futura Medical’s EPS estimate?
Futura Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Futura Medical have?
Futura Medical has 1,482,327,800 shares outstanding.
What happened to Futura Medical’s price movement after its last earnings report?
Futura Medical reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Futura Medical?
Currently, no hedge funds are holding shares in DE:GYX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology